Trial NCT03988114

View at ClinicalTrials.gov 
Org. Study IDs: 17395
Secondary IDs: 2019-001781-16 I3Y-MC-JPCX

Last trial update was posted on 2019-09-06

MeSH Interventions

Aromatase Inhibitors

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

Strategic decision due to emerging new data for patients with HR+, HER2- metastatic breast cancer.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID